AzTrials
AzTrials

Physical DisabilityNCT04212442

Improving Aging in Place in Subsidized Housing

A study testing Independent Living Program for Affordable Housing. in people with Physical Disability and Cognitive Impairment, run by University of Pennsylvania at 13 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study will evaluate the feasibility and preliminary effectiveness of an adapted version of the Function Focused Care intervention, delivered by telephone, for improving aging in place for older adults living in subsidized housing. Read more about this study

Who is it for?
Ages 62 years and olderHealthy volunteers can take part
What is being tested?
Independent Living Program for Affordable Housing.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
13 sitesUnited States
Study dates
13 Jan 2020to 2 Mar 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 62 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Lives in an included subsidized housing setting
  • 62 years of age or older
  • Speaks English or Spanish well or very well
  • Able to provide informed consent OR able to provide assent and has a proxy who provides informed consent on his/her behalf
  • Has difficulty or needs help in at least 1 ADL and/or IADL OR has mild cognitive impairment or mild dementia based on their Montreal Cognitive Assessment (MoCA) score
  • Not enrolled in hospice
Show all 11Show fewer
  • Speaks English or Spanish well or very well
  • Able to provide informed consent
  • Spends at least an hour per week with the resident
  • Speaks English or Spanish well or very well
  • Able to provide informed consent

Who cannot join

  • Younger than 62 years of age
  • Does not speak English or Spanish
  • Lacks decision making capacity and lacks a proxy to consent on his/her behalf
  • Does not have functional impairment or cognitive impairment
  • Has moderate to severe dementia based on his/her MoCA score
  • Is enrolled in hospice
Show all 11Show fewer
  • Does not speak English or Spanish
  • Unable to provide informed consent
  • Does not spend at least an hour per week with the resident
  • Does not speak English or Spanish
  • Unable to provide informed consent

Trial locations and contacts

13 sites in 1 country.

13 sites in 1 country

United States13 sites
  • Northgate 2

    Camden, New Jersey, 08102

  • Haven House

    Cape May, New Jersey, 08204

  • Victorian Towers

    Cape May, New Jersey, 08204

  • Stonegate 1

    Pennsauken, New Jersey, 08109

  • Stonegate 2

    Pennsauken, New Jersey, 08109

  • Mantua Presbyterian Apartments

    Philadelphia, Pennsylvania, 19104

  • Old City Presbyterian Apartments

    Philadelphia, Pennsylvania, 19106

  • Casa Carmen Aponte

    Philadelphia, Pennsylvania, 19122

  • Neumann Senior Housing

    Philadelphia, Pennsylvania, 19125

  • St. Francis VIlla

    Philadelphia, Pennsylvania, 19125

  • Paschall Senior Housing

    Philadelphia, Pennsylvania, 19142

  • Greenway Presbyterian Apartments

    Philadelphia, Pennsylvania, 19143

  • Jackson Place

    Philadelphia, Pennsylvania, 19148

Other trials in United States

About this study

Official title: Improving Aging in Place for Older Adults in Subsidized Housing

This pilot study will evaluate the feasibility and preliminary effectiveness of an adapted version of the Function Focused Care intervention, delivered by telephone, for improving aging in place for older adults living in subsidized housing. The study will include participants with and without mild cognitive impairment or mild dementia and will examine whether the study outcomes differ by cognitive status. Findings from this study will provide new information about how to optimize function and physical activity among older adults with and without cognitive impairment living in subsidized housing.

Read the detailed description

Millions of older adults with low incomes live in federally-subsidized housing and are at disproportionate risk for nursing home admission. Effective approaches are needed to improve aging in place for this vulnerable population. The objective of this study is to pilot test the feasibility and preliminary effectiveness of a telephone-based intervention to improve aging in place for older adults living in subsidized housing. In the first phase of this study, the investigators used methods of implementation science to adapt an existing intervention, Function Focused Care for Assisted Living, to the unique setting of affordable housing. Function Focused Care is a philosophy of care in which assisted living staff members engage residents in functional and physical activity during all care interactions. Prior research supports the effectiveness of Function Focused Care for maintaining function and increasing physical activity among older adults in assisted living settings.

In the first phase of this study, the investigators interviewed subsidized housing stakeholders - including residents, staff members, and caregivers - to identify barriers, facilitators, and needed adaptations to Function Focused Care for Assisted Living. The investigators used the findings from these interviews to adapt the intervention. In this 2-month pilot study, the investigators will use a wait-list control design with site randomization to assess the feasibility and preliminary effectiveness of the adapted intervention. The investigators will recruit individuals with and without mild cognitive impairment or mild dementia and will examine whether the study outcomes differ by cognitive status. The findings from this study will provide new information about how to optimize function and physical activity among older adults with and without cognitive impairment living in subsidized housing.

Being tested
Independent Living Program for Affordable Housing.
Keywords
aging in place, physical activity, cognitive impairment, dementia, affordable housing, subsidized housing, functional impairment, home health aides, activities of daily living
Medical subject headings
Cognitive Dysfunction, Motor Activity, Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Independent Living Program for Affordable Housing.Behavioural

    Two-month program intended to increase physical activity and function, including the following 4 steps:

    1. Environmental and Policy Assessments: Nurse facilitator works with the affordable housing staff to identify and recommend feasible interventions to alter the environment, policy, and procedures to optimize resident function and physical activity.
    2. Education: Nurse educates residents and study partners in the principles of the Independent Living Program, using established materials and adult learning techniques.
    3. Establishing Resident Goals: The nurse completes Capability Assessment Forms and helps resident set goals to increase function and physical activity.
    4. The nurse helps to motivate and mentor residents and study partners to achieve and maintain their goals, using evidence-based approaches.
Study groups in NCT04212442
Study groupRoleWhat they receive
Immediate InterventionExperimentalUpon enrollment, participants receive the adapted telephone-based intervention, the Independent Living Program for Affordable Housing, for two consecutive months.
Receives: Behavioral: Independent Living Program for Affordable Housing.
Wait-list ControlExperimentalTwo months after study enrollment, participants receive the adapted telephone-based intervention, the Independent Living Program for Affordable Housing, for two consecutive months.
Receives: Behavioral: Independent Living Program for Affordable Housing.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Precipitating Events Project (PEP) Functional Status Scale From Baseline to 2 Months for Immediate Intervention Sites and Waitlist Control Sites

    Self-reported ability to perform 7 ADLs, 5 IADLs, and 3 mobility tasks (Range, 0-30; higher scores indicate more functional impairment)

    Measured: Baseline, 2 months

  2. Change in Short Physical Performance Battery Score From Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites

    Objective measure of lower extremity functioning in older adults (Range, 0-12; higher scores indicate worse lower extremity functioning)

    The measure will be collected only if in-person contact is possible during the COVID-19 outbreak.

    Measured: Baseline, 2 months

  3. Change in Average Step Counts From Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites

    Measured using Fitbit

    Measured: Measured continuously from 0-2 months

  4. Change in Time Spent in Differing Levels of Activity From Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites

    Measured using Fitbit (minutes spent in each of 4 levels of activity: sedentary; lightly active; fairly active; very active)

    Measured: Measured continuously from 0-2 months

  5. Change in Physical Activity Scale for the Elderly (PASE) Score From Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites

    Self-reported physical activity (Range, 0-793; higher scores indicate greater physical activity)

    Measured: Baseline, 2 months

  6. Feasibility of Study Recruitment, Measured as Percentage of Eligible Participants Recruited

    Assessed using participant responses to invitation to participate in the study (enrolled vs. refused)

    Measured: 0-4 months

  7. Feasibility of Study Retention, Measured as Percentage of Participants Retained Over Study Follow-up

    Assessed as percentage of participants who remain enrolled in the study

    Measured: 0-4 months

  8. Acceptability Assessed Using a Survey Question

    Self-reported acceptability of the intervention (5-point Likert scale ranging from very unacceptable (1) to very acceptable (5); higher numbers indicate higher acceptability)

    Measured: 2 months

  9. Number of Participants With High Fidelity to Treatment Protocol, Measured Using Fidelity Checklist

    Number of participants with >80% fidelity to treatment protocol, measured using fidelity checklist including each study protocol task

    Measured: 0-4 months

  10. Fidelity to Motivational Interviewing, Measured Using the Motivational Interviewing Treatment Integrity Scale (MITI 4)

    Assessed by psychologist (4 global scores, scored on a 5-point Likert scale from 1 (low) to 5 (high))

    Measured: 2 months

Secondary outcomes (8)
  1. Change in EuroQol 5 Dimensions (EQ-5D-5L) Scale From Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites

    Self-reported measure (Range, 11111-55555, converted to a single index utility score ranging from of 0-1; higher scores indicate better quality of life)

    Measured: Baseline, 2 months

  2. Change in Geriatric Depression Scale Short Form (GDS Short Form) Score From Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites

    Self-reported measure of depressive symptoms (Range, 0-15; score of 5-8 suggests mild depression, 9-11 moderate depression, and 12-15 severe depression)

    Measured: Baseline, 2 months

  3. Percentage of Participants With a Hospitalization During the Study Period (Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites)

    Self-reported hospitalization

    Measured: Baseline, 2 months

  4. Change in Number of Hospitalizations During the Study Period (Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites)

    Self-reported number of hospitalizations

    Measured: Baseline, 2 months

  5. Percentage of Participants With an Emergency Department Visit During the Study Period (Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites)

    Self-reported emergency department visit

    Measured: Baseline, 2 months

  6. Change in Number of Emergency Department Visits During the Study Period (Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites)

    Self-reported number of emergency department visits

    Measured: Baseline, 2 months

  7. Percentage of Participants With a Move to a Higher Level of Care (Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites)

    Self-reported or emergency contact-reported move to a higher level of care, defined as a move to assisted living, board and care, or nursing home

    Measured: Baseline, 2 months

  8. Percentage of Participants With a Skilled Nursing Facility Stay (Baseline to 2 Months for Immediate Intervention and Waitlist Control Sites)

    Self-reported skilled nursing facility stay

    Measured: Baseline, 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Dec 2019
  2. Study start13 Jan 2020
  3. Primary completion24 Jan 2023
  4. Study completion2 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a pilot study testing the adapted Function Focused Care intervention. The study employs a wait-list control design and site randomization.
Masking
None (open label)
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04212442
Sponsor's protocol ID
831642
Other IDs
K76AG057016
Status last verified
Nov 2024
First submitted
16 Dec 2019
Last updated
15 Nov 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Will share data based on request and following the development of an IPD sharing plan with the IRB.

Questions about this trial

What is this clinical trial studying?

A study testing Independent Living Program for Affordable Housing. in people with Physical Disability and Cognitive Impairment, run by University of Pennsylvania at 13 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 13 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Nov 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Precipitating Events Project (PEP) Functional Status Scale From Baseline to 2 Months for Immediate Intervention Sites and Waitlist Control Sites (time frame: Baseline, 2 months). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in